Movement Alert｜MicroPort MedBot Rises 5.32% in Regular Trading, Toumai 200-Unit Global Installation Milestone Continues to Drive Momentum

Market Focus07-02

On July 2, MicroPort MedBot-B rose 5.32% in regular trading, trading at 23.54 HKD/share, with turnover of approximately 26.04 million HKD.

The rally was driven by continued market reaction to the company's announcement that its core product, the Toumai laparoscopic surgical robot, surpassed 200 commercial installations globally. The 200th unit was deployed at Spain's top medical institution HM Hospitales, with all installations having received end-customer acceptance reports. Furthermore, Toumai's global commercial orders have exceeded 300 units, with total orders approaching 400. New orders secured in the first half already surpass the full-year total of last year.

Adding to the positive momentum, Toumai's remote surgery full-department application received EU CE certification in June, making it the world's first remote surgical robot to obtain this approval. Multiple institutions including UBS, JP Morgan, and CITIC Construction Investment have issued positive ratings, citing strong overseas sales potential and expectations that the company could achieve breakeven in the first half of the year, with overseas revenue projected to exceed 80% of total revenue.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192914405?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 09:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192914405","market":"hk","top_or_hot":-1,"title":"Movement Alert｜MicroPort MedBot Rises 5.32% in Regular Trading, Toumai 200-Unit Global Installation Milestone Continues to Drive Momentum","media":"Market Focus","content":"<p><p>On July 2, MicroPort MedBot-B rose 5.32% in regular trading, trading at 23.54 HKD/share, with turnover of approximately 26.04 million HKD.</p><p>The rally was driven by continued market reaction to the company's announcement that its core product, the Toumai laparoscopic surgical robot, surpassed 200 commercial installations globally. The 200th unit was deployed at Spain's top medical institution HM Hospitales, with all installations having received end-customer acceptance reports. Furthermore, Toumai's global commercial orders have exceeded 300 units, with total orders approaching 400. New orders secured in the first half already surpass the full-year total of last year.</p><p>Adding to the positive momentum, Toumai's remote surgery full-department application received EU CE certification in June, making it the world's first remote surgical robot to obtain this approval. Multiple institutions including UBS, JP Morgan, and CITIC Construction Investment have issued positive ratings, citing strong overseas sales potential and expectations that the company could achieve breakeven in the first half of the year, with overseas revenue projected to exceed 80% of total revenue.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜MicroPort MedBot Rises 5.32% in Regular Trading, Toumai 200-Unit Global Installation Milestone Continues to Drive Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜MicroPort MedBot Rises 5.32% in Regular Trading, Toumai 200-Unit Global Installation Milestone Continues to Drive Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-02 09:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 2, MicroPort MedBot-B rose 5.32% in regular trading, trading at 23.54 HKD/share, with turnover of approximately 26.04 million HKD.</p><p>The rally was driven by continued market reaction to the company's announcement that its core product, the Toumai laparoscopic surgical robot, surpassed 200 commercial installations globally. The 200th unit was deployed at Spain's top medical institution HM Hospitales, with all installations having received end-customer acceptance reports. Furthermore, Toumai's global commercial orders have exceeded 300 units, with total orders approaching 400. New orders secured in the first half already surpass the full-year total of last year.</p><p>Adding to the positive momentum, Toumai's remote surgery full-department application received EU CE certification in June, making it the world's first remote surgical robot to obtain this approval. Multiple institutions including UBS, JP Morgan, and CITIC Construction Investment have issued positive ratings, citing strong overseas sales potential and expectations that the company could achieve breakeven in the first half of the year, with overseas revenue projected to exceed 80% of total revenue.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"","article_id":"1192914405","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192914405","pubTimestamp":1782956741,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 2, MicroPort MedBot-B rose 5.32% in regular trading, trading at 23.54 HKD/share, with turnover of approximately 26.04 million HKD.The rally was driven by continued market reaction to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"动静快讯|微创医疗机器人常规交易涨5.32%图迈200台全球安装里程碑继续推动势头","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"On July 2, MicroPort MedBot-B rose 5.32% in regular trading, trading at 23.54 HKD/share, with turnover of approximately 26.04 million HKD.The rally was driven by continued market reaction to the company's announcement that its core product, the Toumai laparoscopic surgical robot, surpassed 200 commercial installations globally. The 200th unit was deployed at Spain's top medical institution HM Hospitales, with all installations having received end-customer acceptance reports. Furthermore, Toumai's global commercial orders have exceeded 300 units, with total orders approaching 400. New orders secured in the first half already surpass the full-year total of last year.Adding to the positive momentum, Toumai's remote surgery full-department application received EU CE certification in June, making it the world's first remote surgical robot to obtain this approval. Multiple institutions including UBS, JP Morgan, and CITIC Construction Investment have issued positive ratings, citing strong overseas sales potential and expectations that the company could achieve breakeven in the first half of the year, with overseas revenue projected to exceed 80% of total revenue.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192914405","isCrawlerRequest":true}